Concepta Plc (CPT.L) Announced that its myLotus® user pregnancies have now moved into double figures. The first myLotus® 'live births' are expected later this year. User testimonials for the myLotus® monitor and app remain exceptional with many users providing personal video feedback and testimonials on their menstrual cycle hormone changes and profiles ('signatures') to enable other women to better understand their fertility journey (www.mylotus.com). myLotus® the revolutionary home based, selftest product was launched in the UK in November 2018 with the first wave of users being women who had historically struggled to fall pregnant (some after many years of 'trying to conceive') after using traditional less responsive fertility tests. myLotus® is available to women who are planning to start a family or for those who have previously struggled to naturally conceive, enabling couples a cost effective and technically leading alternative prior to considering more costly IVF treatment. The Company expects to release further hormone health and wellbeing tests to complement its fertility offering later this year.
Concepta PLC, the innovative UK personalised healthcare company and developer of the proprietary self-test platform and suite of emerging test products targeting the mobile health market with a primary focus on women's fertility and hormone health announces today its myLotus ® user pregnancies have now moved into double figures.
RNS Number: 1328 C Concepta PLC 13 June 2019. Concepta Plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus ®, targeted at the personalised mobile health market with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained...
Concepta Plc, the innovative UK personalised healthcare company and developer of the proprietary self-test platform and suite of emerging test products targeting the mobile health market with a primary focus on women's fertility and hormone health, confirms the Notice of Annual General Meeting and associated form of proxy will be sent to shareholders...
RNS Number: 8860 Y Concepta PLC 14 May 2019. Concepta Plc, the innovative UK personalised healthcare company and developer of the proprietary self-test platform and suite of emerging test products targeting the mobile health market with a primary focus on women's fertility and hormone health, announces today its final results for the twelve months to 31...
Concepta Plc, the innovative UK personalised healthcare company and developer of the proprietary self-test platform and suite of emerging test products targeting the mobile health market with a primary focus on women's fertility and hormone health announces today its first pregnancies and user testimonials for the myLotus ® monitor and app..
RNS Number: 6280 X Concepta PLC 30 April 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5994 X Concepta PLC 30 April 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 4328 X Concepta PLC 29 April 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2286 X Concepta PLC 26 April 2019. Following Admission of the new ordinary shares of 2.5 p each issued in the Placing announced on 8 April 2019, the directors shareholdings are as follows.. Concepta plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus ®, targeted at the personalised mobile health...
The 76,750,000 new ordinary shares of 2.5 pence per share issued in the placing at 3 pence per share, as announced on 8 April 2019, are expected to be admitted to trading at 8.00 a.m. on 26 April 2019.. Concepta Plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus ®, targeted at the personalised mobile health...
Andrew Hore Quoted Micro 15 April 2019 NEX: #HASH #ESO #ANGP #LUCE #NQMI AIM: #SUMO #DEST #ANX #RAI #SAF #IQG #LWRF #GOR #SML #PSL #ROSE #CPT LSE: #NANO #BON #CGO #TOOP #NFX #ZEG #WDC
RNS Number: 3578 V Concepta PLC 08 April 2019 Release: 7:00AM, Monday 8 April 2019. Placing to raise £2,302,500; Notice of General Meeting. Concepta PLC, the pioneering UK healthcare company and developer of the proprietary myLotus product targeting the personalised mobile health market with a primary focus on women's fertility and hormone health, is pleased...
Concepta Plc (CPT.L) Announced that it has agreed to supply the myLotusR product for women's fertility and hormone testing to Boots UK, a member of Walgreens Boots Alliance. myLotusR the revolutionary home based, self-test product was launched in November 2018 with early 'trying to conceive' users providing personal video feedback and testimonials on their menstrual cycle hormone changes and hormone patterns (signatures) enabling women to better understand their menstrual cycle and fertility journey. The Boots supply agreement represents the first commercial partnership forming part of the company's EU roll-out plans. myLotusR recently received CE-Mark certification and the agreement allows the company to sell its product online at www.Boots.com as well as to other partners across EU markets (CE-Mark territories).
Concepta to supply myLotus ® to Boots UK. Concepta Plc, the innovative UK personalised healthcare company and developer of the proprietary self-test platform and suite of emerging test products targeting the mobile health market, is pleased to announce it has agreed to supply the myLotus ® product for women's fertility and hormone testing to Boots UK, a...
Concepta Plc (CPT.L) Announced that it has agreed to supply the myLotusR product to Walgreens Boots Alliance (WBA) for women's fertility and hormone testing. myLotusR the revolutionary home based, self-test product was launched in November 2018 with early 'trying to conceive' users providing personal video feedback and testimonials on their menstrual cycle hormone changes and hormone patterns ('signatures') enabling women to better understand their menstrual cycle and fertility journey (www.mylotus.com)
RNS Number: 5654 S Concepta PLC 12 March 2019 Concepta PLC. Concepta Plc, the innovative UK personalised healthcare company and developer of the proprietary self-test platform and suite of emerging test products targeting the mobile health market is pleased to announce it has agreed to supply the myLotus ® product to Walgreens Boots Alliance for women's...
Concepta Plc (CPT.L) Announced the successful launch in the UK of its breakthrough myLotusR product for women's fertility. myLotusR allows women to self-test to identify their optimal fertile days thereby improving their chances of naturally getting pregnant. myLotusR enables women to monitor their fertile phase as part of their menstrual cycle and is the only home test to 'quantitatively' measure personalised hormone levels and the 'rate-of-change' of these levels preceding ovulation to help aid a natural conception. Users measure, record and track their hormone levels and follow their fertility journey in an accompanying free downloadable app.
Concepta Plc
CPT.L
Concepta Plc
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    188.20M

Classification

Market Indices-

Locations

HQ
The Exchange
Colworth Park
Sharnbrook
MK44 1LQ
Watchlist